2024 SPEAKER FACULTY

Your World-Class 2024 Speaker Faculty Include

Abbas El Sahili

Chief Executive Officer

Singzyme

Adalynn Harris

President & Chief Executive Officer

NA

Ahsan Arozullah

Senior Vice President, Head of Oncology Development

Astellas Innovation Management LLC

Alice Yam

Vice President, Drug Discovery

Sutro Biopharma

Amit Garg

Executive Director, Clinical Pharmacology Oncology

Pfizer

Amy Johnson

Vice President, Medical Affairs

Vincerx Pharma

Andrew Kim

Director, MSAT Bioprocessing

Pfizer

Anikó Pálfi

Director, Biochemistry & Cell Biology

Heidelberg Pharma

Anton Rosenbaum

Senior Group Director, Integrated Bioanalysis

AstraZeneca

Bilal Piperdi

Vice President, Clinical Development Oncology

Gilead Sciences

Bill Mallet

Senior Director, Target Validation

Bolt BioTherapeutics

Bowen Jiang

Associate Director, Biologics Drug Product Development & Manufacturing

Exelixis

Candice Wong

Senior Director, Engineering & External Process Development

Pfizer

Cen Guo

Clinical Pharmacology Lead

Pfizer

Charles Morgan

Head, Regulatory CMC

Denali Therapeutics

Christian Rohlff

Chief Executive Officer

Oxford BioTherapeutics

Christina Vasalou

Director, Head of ADC Translational PKPD

AstraZeneca

Dan Calarese

Director, Innovation & Strategy

Sutro Biopharma

Do-Hyun Nam

Professor, Department of Neurosurgery

Sungkyunkwan University School of Medicine

Engin Ayturk

Senior Director, CMC Bioconjugation, Process Development & Manufacturing

Exelixis

Eshita Khera

Principal Scientist II

Novartis

Esohe Idusogie

Head, Process Quality & CMC Analytical

ADC Therapeutics

Forgivemore Magunda

Principal Pathologist

Pfizer

Frank Comer

Director, Tumor Targeted Delivery, Early Oncology Discovery

AstraZeneca

Gail Lewis

Senior Principal Scientist

Genentech

Gang Yin

Vice President, Research

Sutro Biopharma

Geoff Winters

Associate Director & Functional Lead, ADC Process Development

Zymeworks

George Badescu

Chief Business Officer

Heidelberg Pharma

Gerhard Frey

Vice President, Technology Development

BioAtla

Gilles Gallant

Chief Development Officer

Mythic Therapeutics

Greg Thurber

Associate Professor & Chair, Graduate Education

University of Michigan

Gregory Adams

Chief Scientific Officer

Elucida Oncology

Hans-Peter Gerber

Chief Scientific Officer

Sutro Biopharma

Harshil Renawala

Senior Scientist, Sterile Drug Product Commercialization

Merck & Co

Hema Balachandra

Associate Director, Biologics CMC

Merck & Co

Hetal Sarvaiya

Director, QTAS (DMPK-BA)

AbbVie

Hua Fang

Scientific Director, Clinical Development Oncology

AbbVie

Ilaria Conti

Vice President, Global Early-Stage Clinical Development, Oncology

ADC Therapeutics

Jake Morris

Senior Account Manager & ADC Insights Lead

Beacon Targeted Therapeutics

James Palacino

Head, Research

Orum Therapeutics

James Stec

Executive Director, Medical Affairs

ImmunoGen

Jan Pinkas

Chief Scientific Officer

Pyxis Oncology

Jay Harper

Director, Early Oncology

AstraZeneca

Jay Mettetal

Senior Director, Oncology Bioscience

AstraZeneca

Jeffrey Liu

Chief Scientific Officer

Huadong Medicine

Jeffrey Settleman

Senior Vice President, Chief Scientific Officer, Oncology Research and Development

Pfizer

Jia He

Senior Research Analyst

Beacon Targeted Therapeutics

Jian Chen

Director, Translational Research & Preclinical Development

BioAtla

Jinwon Jung

Senior Director, Protein Engineering

ABL Bio

Joanne Lim

Associate Director, Immunology

Orum Therapeutics

John Lambert

Independent Consultant & Honorary Professor

Queens University Belfast

Jutta Deckert

Vice President, Research & Development

Iksuda Therapeutics

Kaijie He

Vice President, Cancer Biology & ADC

Innovent Biologics

Kati Räsänen

Director, ADC Discovery

SOTIO Biotech

Kevin Hamblett

Senior Director, ADC Biology

Pfizer

Krishna Bajjuri

Senior Director, Chemistry

Sutro Biopharma

Kristin Westphal

External Process Development Manager

Pfizer

Labros Meimetis

Research Assistant Professor, Department of Radiology

University of Wisconsin

Lara McGrath

Director, Translational Medicine

AstraZeneca

Laura Kreckler

Senior Principal Research Scientist

AbbVie

Laurie Mlinar

Principal Research Scientist II

AbbVie

Linjie Han

Associate Director, Analytical Development, Operations S&T, Biologics

AbbVie

Lisa McDermott

Director, Process & Analytical Development

MilliporeSigma

Llorente Bonaga

Senior Director, Global Regulatory Affairs & Clinical Safety, CMC

Merck & Co

Maria Elena Guadagno

Technical Operations & Business Executive Director

BSP Pharmaceuticals

Martin Steegmaier

Chief Scientific Officer

SOTIO Biotech

Martina McDermott

Adjunct Assistant Professor

UCLA

Mary Elmer

Executive Director, Patient Engagement Oncology

Merck & Co

Mary Jane Hinrichs

Senior Vice President, Global Head of Early Development

Ipsen Pharma

Melanie Frigault

Vice President, Translational Medicine

Vincerx Pharma

Mimi Zhu

Senior Manager, Downstream Process Development & Operations

GlaxoSmithKline

Nagendra Chemuturi

Senior Director, ADME

Eli Lilly

Naomi Hunder

Chief Medical Officer

ProfoundBio

Naresh Jain

President & Chief Executive Officer

NJ Bio, Inc.

Nicolas Agard

Senior Principal Scientist

Genentech

Nicole Swope

Senior Scientist, Analytical Sciences

AstraZeneca

Patrick Van Berkel

Chief Scientific Officer

ADC Therapeutics

Patrick Zweidler-McKay

Executive Medical Director

ImmunoGen

Paul Davis

Independent Consultant

Paul Jaminet

Chief Executive Officer

Angiex

Paul Song

Chief Scientific Officer

GeneQuantum Healthcare

Paul Thomas

Principal Research Scientist II, Biologics Analytical Research & Development

AbbVie

Paul Wolstenholme-Hogg

Vice President, Medicinal Chemistry

ADC Therapeutics

Petra Bennington

Director, Analytical Research & Development

Merck & Co

Philip Kuhl

Distinguished Scientist, Bioconjugation & Chemistry Commercialization

Merck & Co

Pralay Mukhopadhyay

Vice President, Medicine Development Leader, Oncology R&D

GlaxoSmithKline Plc

Puja Sapra

Senior Vice President, Biologics Engineering & Oncology Targeted Discovery, Oncology R&D

AstraZeneca

Radhika Balasubramani

Director, Technical Product Steward, Antibody Drug Conjugates

Merck & Co

Rajkumar Ganesan

Executive Director, Oncology

Amgen

Rakesh Dixit

Independent Consultant

Ricardo Zwirtes

Executive Director, Global Clinical Lead

Daiichi Sankyo, Inc.

Ricki Fairley

Chief Executive Officer & Co-founder

TOUCH Black Breast Cancer Association

Robert Lutz

Chief Scientific Officer

Iksuda Therapeutics

Ross Bemowski

Associate Director, API R&D

Merck & Co

Sandhya Girish

Vice President, Clinical Pharmacology Sciences

Gilead Sciences

Sarah Kiehna

Director, Analytical Development & Quality Control

AbbVie

Sayumi Yamazoe

Associate Director

Bristol Myers Squibb

Scott Collins

Director, Non-Clinical Development

Mersana Therapeutics

Scott Peterson

Head of ADC Discovery and Cancer Immunology

Pfizer

Seb Caille

Scientific Director, Process Development

Amgen

Shawn Zhang

Chief Scientific Officer

Ambrx, a Johnson & Johnson Company

Shotaro Nagase

Associate Researcher

Daiichi Sankyo

Shu-Hui Liu

Chief Scientific Officer

Multitude Therapeutics

Simon Letarte

Director, Extended Structural Characterization

Gilead Sciences

Sophia Xu

Director, Clinical Bioanalysis

Daiichi Sankyo

Srinath Thirumalairajan

Director, Process Engineering

Pfizer

Tae Han

Co-founder & Chief Strategy Officer

ProfoundBio

Teresa Mako

Scientist I, Medicinal Chemistry

Orum Therapeutics

Timothy Lowinger

Chief Science & Technology Officer

Mersana Therapeutics

Tomohiro Fujii

ADC Researcher

Ajinomoto Bio-Pharma Services

Torsten Hechler

Senior Vice President, ADC Research

Heidelberg Pharma Research GmbH

Vikram Shenoy

Senior Scientist I, QTAS (DMPK-BA)

AbbVie

Weijun Li

Senior Director, Biologics Analytical Development & CMC Team Lead

Exelixis

Xiaoli Liao

Principal Scientist II, Operations S&T

AbbVie

Xiaona Jing

Vice President, Global Product Development

Multitude Therapeutics

Yan Zhang

Senior Director, Translational Sciences

Eisai

Yu-Tzu Tsai

Associate Director, ADC & Translational Research

Oxford BioTherapeutics

Yuan Ren

Senior Scientist, Chemical Process Development, Analytical Chemistry

Bristol Myers Squibb

Yuanyuan Li

Director

Mersana Therapeutics

Yuting Huang

Senior Scientist & Group Leader

Pfizer

Zhengqi Zhang

Senior Scientist

Merck & Co

ADC SD Social Card (1)